DrugPatentWatch Database Preview
NOVOSEVEN Drug Profile
» See Plans and Pricing
Summary for Tradename: NOVOSEVEN
| Patents: | 1 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 1 |
| Recent Clinical Trials: | See clinical trials for NOVOSEVEN |
Recent Clinical Trials for NOVOSEVEN
Identify potential brand extensions & biosimilar entrants
| Sponsor | Phase |
|---|---|
| Octapharma | Phase 4 |
| University of Virginia | Phase 4 |
| Joseph Broderick, MD | Phase 3 |
Patent Text Search: US Patents for NOVOSEVEN
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk | NOVOSEVEN | coagulation factor viia (recombinant) | KIT | 103665 | 1 | 2012-10-29 | Start Trial | Corning Incorporated (Corning, NY) | 2033-04-24 | search | ||
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for NOVOSEVEN
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| European Patent Office | 2796430 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
